Low dose cabergoline for hyperprolactinaemia is not associated with clinically significant valvular heart disease
نویسندگان
چکیده
منابع مشابه
Valvular Heart Disease in Patients with Prolactinomas on Cabergoline Treatment
Dopamine agonists are the first line treatment of prolactinomas and Parkinson’s disease. Has shown an association between the use of high doses of ergot dopamine agonists, cabergoline and pergolide, and development of clinically significant (moderate to severe) heart valve regurgitation, valvular thickening and retraction in patients with Parkinson’s disease [1,2]. Because of this, he has appea...
متن کاملIs Subclinical Thyroid Dysfunction Associated With with Coronary Heart Disease?
Introduction: Previous cohort studies reported contradictory data on the association between subclinical thyroid dysfunction and coronary heart disease (CHD). Regarding this, the present study was conducted to illuminate this relationship. Materials and Methods: For the purpose of the study, 3,066 participants employed in a study conducted by Azizi et al. aged ≥ 20 years were subjected to thyro...
متن کاملValvular heart disease associated with taking low-dose pergolide for restless legs syndrome.
A 49-year-old female took low-dose pergolide (625 microg daily) for approx. 5 years (approximately cumulative dose 1.140 g/5 years) for the treatment of restless legs syndrome. She developed moderate to severe mitral and aortic valve insufficiency, requiring semi-urgent double-valve replacement. The initial diagnosis of rheumatic valve disease was refuted on histological examination of the valv...
متن کاملValvular heart disease in hyperprolactinemic patients treated with low doses of cabergoline.
Bohun CM, Potts JE, Casey BM, Sandor GG. A population-based study of cardiac malformations and outcomes associated with dextrocardia. Am J Cardiol. 2007;100:305–9. Icardo JM, Garcia Rincon JM, Ros MA. Malformaciones cardı́acas, heterotaxia y lateralidad. Rev Esp Cardiol. 2002;55:962–74. Perloff JK. The cardiac malpositions. Am J Cardiol. 2011;108:1352–61. Palacios IF. Sustitución percutánea de v...
متن کامل[Valvular heart disease associated with benfluorex].
We report the first case of valvular heart disease due to benfluorex. A 50-year-old woman who had been taking the anorectic agent benfluorex intermittently for one year developed severe fibrosis and regurgitation of the mitral, aortic and tricuspid valves. Clinical, echocardiographic and histopathological findings were analogous to those reported with fenfluramine and dexfenfluramine. The simil...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Endocrinology
سال: 2008
ISSN: 0804-4643,1479-683X
DOI: 10.1530/eje-08-0365